Evidence map›Paper›PMID 32302236›Full record

SynthesisJCO global oncology2020

Mobile Technologies and Cervical Cancer Screening in Low- and Middle-Income Countries: A Systematic Review.

Dongyu Zhang, Shailesh Advani, Jo Waller, Ana-Paula Cupertino, Alejandra Hurtado-de-Mendoza, Anthony Chicaiza, Peter J Rohloff, Tomi F Akinyemiju, Eduardo Gharzouzi, Megan J Huchko and 2 more

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in JCO global oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 2 pooled it
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 2 syntheses or guidelines pooled it, 65 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. The Role of Health Information Technology in Improving Awareness of Human Papillomavirus and Human Papillomavirus Vaccine Among U.S. Adults.Telemedicine journal and e-health : the official journal of the American Telemedicine Association · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 3 countries.

Dongyu ZhangDepartment of Oncology, Georgetown University School of Medicine, Washington, DC.
Shailesh AdvaniDepartment of Oncology, Georgetown University School of Medicine, Washington, DC.
Jo WallerDepartment of Behavioural Science and Health, University College London, London, United Kingdom.
Ana-Paula CupertinoLatino Cancer Disparities Center, John Theurer Cancer Center, Hackensack, NJ.
Alejandra Hurtado-de-MendozaDepartment of Oncology, Georgetown University School of Medicine, Washington, DC.
Anthony ChicaizaDepartment of Oncology, Georgetown University School of Medicine, Washington, DC.
Peter J RohloffCenter for Research in Indigenous Health, Wuqu' Kawoq, Tecpán, Guatemala.
Tomi F AkinyemijuDepartment of Population Health Sciences, Duke University School of Medicine, Durham, NC.
Eduardo GharzouziIntegra Cancer Institute, Guatemala City, Guatemala.
Megan J HuchkoDuke Global Health Institute, Duke University, Durham, NC.
Joaquin BarnoyaUnidad de Cirugia Cardiovascular de Guatemala, Guatemala City, Guatemala.
Dejana BraithwaiteDepartment of Oncology, Georgetown University School of Medicine, Washington, DC.
Georgetown University · USDuke University · USBrigham and Women's Hospital · USCentro de Epilepsia y Neurocirugía Funcional · GTNational Institutes of Health · USUnidad de Cirugía Cardiovascular de Guatemala · GTUniversity College London · GB

Funding

Institutional Career Development CoreKL2TR001432 · NCATS · GEORGETOWN UNIVERSITY · PI UMANS, JASON G · 2015 to 2024
$7.5M
NCATS NIH HHS KL2 TR001432
6 · The paper itself

Abstract

purposeCervical cancer screening is not well implemented in many low- and middle-income countries (LMICs). Mobile health (mHealth) refers to utilization of mobile technologies in health promotion and disease management. We aimed to qualitatively synthesize published articles reporting the impact of mHealth on cervical cancer screening-related health behaviors.

methodsThree reviewers independently reviewed articles with the following criteria: the exposure or intervention of interest was mHealth, including messages or educational information sent via mobile telephone or e-mail; the comparison was people not using mHealth technology to receive screening-related information, and studies comparing multiple different mHealth interventional strategies were also eligible; the primary outcome was cervical cancer screening uptake, and secondary outcomes included awareness, intention, and knowledge of screening; appropriate research designs included randomized controlled trials and quasi-experimental or observational research; and the study was conducted in an LMIC.

resultsOf the 8 selected studies, 5 treated mobile telephone or message reminders as the exposure or intervention, and 3 compared the effects of different messages on screening uptake. The outcomes were diverse, including screening uptake (n = 4); health beliefs regarding the Papanicolaou (Pap) test (n = 1); knowledge of, attitude toward, and adherence to colpocytologic examination (n = 1); interest in receiving messages about Pap test results or appointment (n = 1); and return for Pap test reports (n = 1).

conclusionOverall, our systematic review suggests that mobile technologies, particularly telephone reminders or messages, lead to increased Pap test uptake; additional work is needed to unequivocally verify whether mhealth interventions can improve knowledge regarding cervical cancer. Our study will inform mHealth-based interventions for cervical cancer screening promotion in LMICs.

Indexed as

Developing CountriesUterine Cervical NeoplasmsEarly Detection of CancerFemaleHumansPapanicolaou TestTechnologyTelemedicine

Identifiers

PMID32302236
PMCPMC7193780
OpenAlexW3017025038

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.